Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Neuroblastoma
NCT00003513Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Dec 1996
- Primary completion
- Mar 1999
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in neuroblastoma, sponsored by Burzynski Research Institute. Started Dec 1996; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00003513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003513.